openPR Logo
Press release

2021-2030 Biosimulation Market Size, Growth and Key Companies – Certara, Dassault Systèmes, Schrödinger Inc., Simulations Plus Inc., Rhenovia Pharma, Insilico Biotechnology AG

10-06-2021 08:16 AM CET | IT, New Media & Software

Press release from: The Business research company

Biosimulation Market

Biosimulation Market

The Business Research Company offers " Biosimulation Global Market Report 2021 - By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutions), COVID-19 Implications And Growth" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The biosimulation market report describes and explains the global biosimulation market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

Place A Direct Purchase Order Of The Report Here
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5337

The biosimulation market consists of sales of biosimulation software and services by entities (organizations, sole traders, and partnerships) that are engaged in garnering a better understanding of biological processes using computer simulations. Biosimulation is a mathematical simulation process that uses computers to replicate biological processes and systems. The aim of biosimulation is a model-based prediction of the dynamics and behavior of biological systems.

The global biosimulation market is expected to grow from $2.71 billion in 2020 to $3.17 billion in 2021 at a compound annual growth rate (CAGR) of 17.1%. The change in growth trend of the biosimulation market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The biosimulation market is expected to reach $5.29 billion in 2025 at a CAGR of 13.7%.

Request For The Sample Of The Biosimulation Market Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5337&type=smp

Some of the major players of the biosimulation market are Certara, Dassault Systèmes, Schrödinger Inc., Simulations Plus Inc., Rhenovia Pharma, Insilico Biotechnology AG, Genedata AG, Entelos Inc., Physiomics plc, Rosa & Co. LLC., In silico biosciences Inc., INOSIM Software, LeadInvent Technologies, Nuventra Pharma, and Archimedes.

The countries covered in the global biosimulation market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global biosimulation market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global biosimulation market is segmented -
1) By Product: Software, Services
2) By Application: Drug Development, Drug Discovery, Others
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Regulatory Authorities, Academic Research Institutions, Others

Read More On The Global Biosimulation Market Report:
https://www.thebusinessresearchcompany.com/report/biosimulation-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Biosimulation Market Characteristics
3. Biosimulation Market Trends And Strategies
4. Impact Of COVID-19 On Biosimulation
5. Biosimulation Market Size And Growth
.....
26. Africa Biosimulation Market
27. Biosimulation Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Biosimulation Market
29. Biosimulation Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Interested to know more about The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2021-2030 Biosimulation Market Size, Growth and Key Companies – Certara, Dassault Systèmes, Schrödinger Inc., Simulations Plus Inc., Rhenovia Pharma, Insilico Biotechnology AG here

News-ID: 2418477 • Views:

More Releases from The Business research company

Prebiotic Ingredients Market Size, Share, Trends, Outlook, Insights 2024-2033
Prebiotic Ingredients Market Size, Share, Trends, Outlook, Insights 2024-2033
The prebiotic ingredients market size has grown rapidly in recent years. It will grow from $6.44 billion in 2023 to $7.16 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increased focus on gut health, rise in digestive health concerns, growing awareness about the health benefits of prebiotic ingredients, rising demand for natural
Polyphenols Market Size, Share, Trends And Forecast To 2024-2033
Polyphenols Market Size, Share, Trends And Forecast To 2024-2033
The polyphenols market size has grown rapidly in recent years. It will grow from $2.14 billion in 2023 to $2.45 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to demand for natural antioxidants and growth in the food and beverage industries, expansion of functional foods and nutraceuticals, development of polyphenol-rich extracts, increase
Phosphoric Acid Market Trends, Size And Overview By 2024-2033
Phosphoric Acid Market Trends, Size And Overview By 2024-2033
The phosphoric acid market size has grown strongly in recent years. It will grow from $49.37 billion in 2023 to $52.52 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in food and beverage industries, production of phosphate-based chemicals, water treatment and purification applications, metal surface treatment processes, demand in pharmaceuticals and
Packaging Machinery Market Segments 2024-2033 | Size, Share Trends And Insights
Packaging Machinery Market Segments 2024-2033 | Size, Share Trends And Insights
The packaging machinery market size has grown strongly in recent years. It will grow from $43.76 billion in 2023 to $46.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased global population and consumer demand, growth in food and beverage industry, expansion of e-commerce and retail packaging, emphasis on automation and efficiency

All 5 Releases


More Releases for Biosimulation

Global Biosimulation Market to witness digitized satiation
In the process of biosimulation, the computer aided mathematical models are used to simulate the biological processes. Biosimulation is an important part of systems biology and helps in the discovery and development of new drugs, in the area of drug metabolism and in the modeling of biomedical systems that are complex. There is a growing demand for reduction in the cost of discovery of new drugs and the risk of failure
The Biosimulation Market to Be Driven By Neurotechnology
The Biosimulation Market is slated to grow unstoppably in the years to come. The healthcare providers are, of late, making way for more specialized and timely treatment through same-day surgeries, outpatient surgeries, and likewise. ASCs (Ambulatory Surgical Centers) are preferred over conventional hospital settings. As such, cost-effective medical services could be provided. This type of customization is expected to take the healthcare vertical by storm in the future. In the process
The Biosimulation Market to stick to digitized innovation
The Biosimulation Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward. Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/methodology/3726 In the process of biosimulation, the computer aided mathematical models are used to simulate
Biosimulation Market Study: An Emerging Hint of Opportunity
Latest released the research study on Global Biosimulation Market, offers a detailed overview of the factors influencing the global business scope. Biosimulation Market research report shows the latest market insights, current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Biosimulation. The study covers emerging player’s data, including: Certara, L.P., Simulations Plus,
Biosimulation Market Growth and Sales Forecast 2016 - 2014
Global Biosimulation Market: Overview Biosimulation refers to the mathematical simulation of biological processes and systems. It is aided by computer and is used for model based calculation of biological systems and processes. TMR’s latest report forecasts strong growth for the global biosimulation market between 2011 and 2018. The market is expected to significantly gain from the increasing use of pharmacokinetic (PKPD) and pharmacodynamics, of which PKPD is the most widely used
Biosimulation Market Size, Industry Analysis & Forecast Report 2017
Biosimulation Market Outlook To 2024 ReportsMonitor.com has added the report, “Biosimulation Market Outlook To 2024: Key Categories (Software, Services), by Application, by End-Use, Regional Segmentation, Pipeline Analysis, Competitive Dynamics, And Segment Forecast” extend across over 103 pages, the far reaching research study offers a 360-degree analysis of the market crosswise over different unequivocal elements, including market share by segmentation type, cost analysis, market effect factors, and marketing strategy and promoting methodology. The